FDA's Hahn: No sign China has affected U.S. drug supply during coronavirus pandemic

With pharmaceutical supply chains under immense pressure due to the novel coronavirus, China's role as a global ingredient producer has come under scrutiny. Despite fears the East Asian nation could shut off the tap for U.S. drugs, the FDA said it hasn't yet noticed major signs for concern.